spacer
spacer
Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Lyase PDB id
2bw7
Jmol
Contents
Protein chains
198 a.a. *
Ligands
APC ×4
ECS ×2
Metals
_CA ×4
_MG ×4
Waters ×139
* Residue conservation analysis
PDB id:
2bw7
Name: Lyase
Title: A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen
Structure: Adenylate cyclase. Chain: a, b, c, d. Fragment: catalytic domain, residues 1005-1199. Synonym: soluble adenylyl cyclase cyac. Engineered: yes
Source: Spirulina platensis. Organism_taxid: 118562. Expressed in: escherichia coli. Expression_system_taxid: 469008.
Biol. unit: Dimer (from PDB file)
Resolution:
2.30Å     R-factor:   0.207     R-free:   0.257
Authors: C.Steegborn,T.N.Litvin,K.C.Hess,A.B.Capper,R.Taussig,J.Buck, L.R.Levin,H.Wu
Key ref:
C.Steegborn et al. (2005). A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen. J Biol Chem, 280, 31754-31759. PubMed id: 16002394 DOI: 10.1074/jbc.M507144200
Date:
12-Jul-05     Release date:   20-Jul-05    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
O32393  (O32393_SPIPL) -  Adenylate cyclase
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1202 a.a.
198 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 3 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: E.C.4.6.1.1  - Adenylate cyclase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: ATP = 3',5'-cyclic AMP + diphosphate
ATP
=
3',5'-cyclic AMP
Bound ligand (Het Group name = APC)
matches with 70.00% similarity
+ diphosphate
      Cofactor: Pyridoxal 5'-phosphate
Pyridoxal 5'-phosphate
Molecule diagrams generated from .mol files obtained from the KEGG ftp site
 Gene Ontology (GO) functional annotation 
  GO annot!
  Biological process     cyclic nucleotide biosynthetic process   1 term 
  Biochemical function     phosphorus-oxygen lyase activity     1 term  

 

 
    reference    
 
 
DOI no: 10.1074/jbc.M507144200 J Biol Chem 280:31754-31759 (2005)
PubMed id: 16002394  
 
 
A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen.
C.Steegborn, T.N.Litvin, K.C.Hess, A.B.Capper, R.Taussig, J.Buck, L.R.Levin, H.Wu.
 
  ABSTRACT  
 
Catechol estrogens are steroid metabolites that elicit physiological responses through binding to a variety of cellular targets. We show here that catechol estrogens directly inhibit soluble adenylyl cyclases and the abundant trans-membrane adenylyl cyclases. Catechol estrogen inhibition is non-competitive with respect to the substrate ATP, and we solved the crystal structure of a catechol estrogen bound to a soluble adenylyl cyclase from Spirulina platensis in complex with a substrate analog. The catechol estrogen is bound to a newly identified, conserved hydrophobic patch near the active center but distinct from the ATP-binding cleft. Inhibitor binding leads to a chelating interaction between the catechol estrogen hydroxyl groups and the catalytic magnesium ion, distorting the active site and trapping the enzyme substrate complex in a non-productive conformation. This novel inhibition mechanism likely applies to other adenylyl cyclase inhibitors, and the identified ligand-binding site has important implications for the development of specific adenylyl cyclase inhibitors.
 
  Selected figure(s)  
 
Figure 1.
FIG. 1. Chemical structures of estrogen and its metabolites. The catechol derivatives 2-CE, 4-CE, and 2-hydroxyestrone are major catabolites of the steroid hormones estrogen and estrone. The hydroxyl group added to the sterol scaffold is needed for subsequent conjugation and decomposition reactions.
Figure 3.
FIG. 3. Structure of CyaC in complex with CE. A, kinetic mechanism for the inhibition of CyaC by 2-CE. AC activities determined at varying substrate and inhibitor concentrations are displayed in a double reciprocal plot. The linear extrapolations intersect on the x-axis, indicating that CE inhibition is non-competitive with the substrate ATP. B, overall structure of CyaC in complex with the substrate analog , -Me-ATP and the inhibitor 2-CE. The two monomers of the homodimer are shown in red and blue, respectively. Two inhibitor molecules occupy the center of the dimer, whereas the active sites are still occupied by the substrate analog and two metal ions. C, detailed view of the interactions between CyaC and the inhibitor 2-CE bound next to the active site, which harbors the substrate analog , -Me-ATP and two divalent metal ions (one magnesium ion colored cyan, and one calcium ion in gray). F[o] - F[c] omit electron density for the inhibitor is shown contoured at 2.5 . Single letter amino acid abbreviations are presented with position numbers. D, electrostatic surface of the 2-CE binding site showing its mainly hydrophobic nature (blue, positively charged; red, negatively charged). The hydroxyl groups of the inhibitor chelate the catalytic magnesium ion (ion A), removing it from its normal binding site (indicated in gray).
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2005, 280, 31754-31759) copyright 2005.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20683624 M.Tresguerres, J.Buck, and L.R.Levin (2010).
Physiological carbon dioxide, bicarbonate, and pH sensing.
  Pflugers Arch, 460, 953-964.  
20018667 M.Tresguerres, S.K.Parks, E.Salazar, L.R.Levin, G.G.Goss, and J.Buck (2010).
Bicarbonate-sensing soluble adenylyl cyclase is an essential sensor for acid/base homeostasis.
  Proc Natl Acad Sci U S A, 107, 442-447.  
19638320 B.Pavan, C.Biondi, and A.Dalpiaz (2009).
Adenylyl cyclases as innovative therapeutic goals.
  Drug Discov Today, 14, 982-991.  
19126549 K.R.Hallows, H.Wang, R.S.Edinger, M.B.Butterworth, N.M.Oyster, H.Li, J.Buck, L.R.Levin, J.P.Johnson, and N.M.Pastor-Soler (2009).
Regulation of epithelial Na+ transport by soluble adenylyl cyclase in kidney collecting duct cells.
  J Biol Chem, 284, 5774-5783.  
19922557 L.Mann, E.Heldman, Y.Bersudsky, S.F.Vatner, Y.Ishikawa, O.Almog, R.H.Belmaker, and G.Agam (2009).
Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect.
  Bipolar Disord, 11, 885-896.  
19337273 S.Pierre, T.Eschenhagen, G.Geisslinger, and K.Scholich (2009).
Capturing adenylyl cyclases as potential drug targets.
  Nat Rev Drug Discov, 8, 321-335.  
18630896 C.Schlicker, A.Rauch, K.C.Hess, B.Kachholz, L.R.Levin, J.Buck, and C.Steegborn (2008).
Structure-based development of novel adenylyl cyclase inhibitors.
  J Med Chem, 51, 4456-4464.  
  17591988 A.Schmid, Z.Sutto, M.C.Nlend, G.Horvath, N.Schmid, J.Buck, L.R.Levin, G.E.Conner, N.Fregien, and M.Salathe (2007).
Soluble adenylyl cyclase is localized to cilia and contributes to ciliary beat frequency regulation via production of cAMP.
  J Gen Physiol, 130, 99.  
16627466 A.M.Stessin, J.H.Zippin, M.Kamenetsky, K.C.Hess, J.Buck, and L.R.Levin (2006).
Soluble adenylyl cyclase mediates nerve growth factor-induced activation of Rap1.
  J Biol Chem, 281, 17253-17258.  
16952140 D.C.Meadows, D.J.Tantillo, and J.Gervay-Hague (2006).
Correlation of biological activity with active site binding modes of geminal disulfone HIV-1 integrase inhibitors.
  ChemMedChem, 1, 959-964.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.